160 related articles for article (PubMed ID: 9233424)
1. Anti-angiogenic gene therapy of malignant glioma.
Stratmann A; Machein MR; Plate KH
Acta Neurochir Suppl; 1997; 68():105-10. PubMed ID: 9233424
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.
Plate KH; Breier G; Millauer B; Ullrich A; Risau W
Cancer Res; 1993 Dec; 53(23):5822-7. PubMed ID: 7694795
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
Plate KH; Breier G; Weich HA; Mennel HD; Risau W
Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.
Machein MR; Risau W; Plate KH
Hum Gene Ther; 1999 May; 10(7):1117-28. PubMed ID: 10340544
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
6. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
7. VEGF-mediated tumour angiogenesis: a new target for cancer therapy.
Martiny-Baron G; Marmé D
Curr Opin Biotechnol; 1995 Dec; 6(6):675-80. PubMed ID: 8527839
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A
Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.
Yao Y; Kubota T; Sato K; Kitai R; Takeuchi H; Arishima H
Acta Neurochir (Wien); 2001; 143(2):159-66. PubMed ID: 11459088
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.
Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E
Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?
Weindel K; Moringlane JR; Marmé D; Weich HA
Neurosurgery; 1994 Sep; 35(3):439-48; discussion 448-9. PubMed ID: 7528359
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
Plate KH; Breier G; Weich HA; Risau W
Nature; 1992 Oct; 359(6398):845-8. PubMed ID: 1279432
[TBL] [Abstract][Full Text] [Related]
17. Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.
Vajkoczy P; Thurnher A; Hirth KP; Schilling L; Schmiedek P; Ullrich A; Menger MD
Oncologist; 2000; 5 Suppl 1():16-9. PubMed ID: 10804086
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
19. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
20. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W
Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
